New drug may tame immunotherapy skin rash without steroids
Symptom relief
Recruiting now
This phase II trial tests whether JAK inhibitors can safely and effectively treat severe skin rashes caused by immune checkpoint inhibitors in cancer patients. The goal is to relieve symptoms without using steroids, which can weaken the anti-cancer effect of immunotherapy. The st…
Phase: PHASE2 • Sponsor: Shixiu Wu • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC